Amura (Drug Discovery) Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Out of Business

Amura (Drug Discovery) General Information

Description

Developer of structure-based drugs designed to provide small-molecule inhibitors against cysteine peptidases. The company's drugs specialize in the treatment of diseases such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain, and malaria as well as possess desirable drug-like properties, thereby facilitating the rapid and innovative discovery of orally active pharmaceutical ingredients across several disease areas, enabling patients to get advanced treatment for their diseases and ensure a speedy recovery.

Contact Information

Website
www.amura.co.uk
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Highfield Court
  • Church Lane, Madingley
  • Cambridge CB23 8AG
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Highfield Court
  • Church Lane, Madingley
  • Cambridge CB23 8AG
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amura (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2017 Completed Out of Business
2. Later Stage VC 28-Feb-2015 Completed Generating Revenue
1. Later Stage VC 31-Jan-2011 Completed Startup
To view Amura (Drug Discovery)’s complete valuation and funding history, request access »

Amura (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amura (Drug Discovery) Investments (1)

Amura (Drug Discovery)’s most recent deal was a Buyout/LBO with Amura Technologies. The deal was made on 06-Jan-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Amura Technologies 06-Jan-2006 Buyout/LBO Biotechnology
To view Amura (Drug Discovery)’s complete investments history, request access »

Amura (Drug Discovery) Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Amura Technologies Cambridge, United Kingdom 1999

Amura (Drug Discovery) FAQs

  • When was Amura (Drug Discovery) founded?

    Amura (Drug Discovery) was founded in 2005.

  • Where is Amura (Drug Discovery) headquartered?

    Amura (Drug Discovery) is headquartered in Cambridge, United Kingdom.

  • What is the size of Amura (Drug Discovery)?

    Amura (Drug Discovery) has 15 total employees.

  • What industry is Amura (Drug Discovery) in?

    Amura (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Amura (Drug Discovery) a private or public company?

    Amura (Drug Discovery) is a Private company.

  • What is Amura (Drug Discovery)’s current revenue?

    The current revenue for Amura (Drug Discovery) is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process